ClinicalTrials.gov record
Completed Phase 2 Interventional

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

ClinicalTrials.gov ID: NCT00521118

Public ClinicalTrials.gov record NCT00521118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 5:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study to Determine the Response to Second Curettage as Initial Management for Persistent Low Risk, Non-metastatic Gestational Trophoblastic Neoplasia

Study identification

NCT ID
NCT00521118
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
64 participants

Conditions and interventions

Interventions

  • Laboratory Biomarker Analysis Other
  • Therapeutic Conventional Surgery Procedure

Other · Procedure

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 8, 2007
Primary completion
Jun 24, 2015
Completion
Jun 24, 2015
Last update posted
Aug 23, 2017

2007 – 2015

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Palo Alto Medical Foundation-Gynecologic Oncology Mountain View California 94040
Stanford Cancer Institute Palo Alto California 94304
UCSF Medical Center-Mount Zion San Francisco California 94115
Olive View-University of California Los Angeles Medical Center Sylmar California 91342
Colorado Gynecologic Oncology Group Aurora Colorado 80010
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045
Hartford Hospital Hartford Connecticut 06102
The Hospital of Central Connecticut New Britain Connecticut 06050
Memorial University Medical Center Savannah Georgia 31404
Northwestern University Chicago Illinois 60611
Borgess Medical Center Kalamazoo Michigan 49001
Bronson Methodist Hospital Kalamazoo Michigan 49007
West Michigan Cancer Center Kalamazoo Michigan 49007
Women's Cancer Center of Nevada Las Vegas Nevada 89169
Virtua Memorial Mount Holly New Jersey 08060
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
Virtua Voorhees Voorhees Township New Jersey 08043
University of New Mexico Cancer Center Albuquerque New Mexico 87102
State University of New York Downstate Medical Center Brooklyn New York 11203
Gynecologic Oncology Network Greenville North Carolina 27834
University of Cincinnati/Barrett Cancer Center Cincinnati Ohio 45219
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa Oklahoma 74146
Abington Memorial Hospital Abington Pennsylvania 19001
Parkland Memorial Hospital Dallas Texas 75235
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
Carilion Clinic Gynecological Oncology Roanoke Virginia 24016

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00521118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2017 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00521118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →